These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 5867)

  • 21. Assessment of immunity to influenza using artifical challenge of normal volunteers with influenza virus.
    Couch RB
    Dev Biol Stand; 1975; 28():295-306. PubMed ID: 1126573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of paramyxovirus-specific haemolysis-inhibiting antibodies separate from haemagglutinating-inhibiting and neuraminidase-inhibiting antibodies. 2. NDV and mumps virus haemolysis-inhibiting antibodies.
    Orvell C
    Acta Pathol Microbiol Scand B; 1976 Dec; 84B(6):451-7. PubMed ID: 998262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laboratory and clinical investigation of the 1974 influenza epidemic in Nigeria.
    David-West TS; Cooke AR
    Bull World Health Organ; 1974; 51(1):103-5. PubMed ID: 4549036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diversity of the antibody response to the different antigenic determinants on the hemagglutinin subunits of influenza viruses.
    Laver WG; Downie JC; Webster RG
    J Immunol; 1976 Feb; 116(2):336-41. PubMed ID: 55438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of antibodies to neuraminidase of A2-Hong Kong and A2-Taiwan influenza viruses after administration of different Hong Kong vaccines and after natural infection in humans.
    Závadová H
    Acta Virol; 1973 Jul; 17(4):287-92. PubMed ID: 4148207
    [No Abstract]   [Full Text] [Related]  

  • 26. Anti-neuraminidase antibody response in serum and nasal secretions following intranasal or subcutaneous inactivated A2-Hong Kong-68 influenza virus vaccine.
    Fedson DS; Fulk RV; Huber MA; Reisberg MA; Kasel JA
    J Immunol; 1971 Sep; 107(3):730-7. PubMed ID: 4999093
    [No Abstract]   [Full Text] [Related]  

  • 27. Secretory antibody responses in cattle infected with foot-and-mouth disease virus.
    Matsumoto M; McKercher PD; Nusbaum KE
    Am J Vet Res; 1978 Jul; 39(7):1081-7. PubMed ID: 209706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccination of an adolescent group with A (H3N2) + A(HSW1N1) bivaccine before an A (H1N1) influenza epidemic.
    Stumpa A; Cihla F; Tůmová B; Husek V; Slezácek J
    Acta Virol; 1979 Sep; 23(5):443-5. PubMed ID: 42307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [On the antigenicity of influenza virus aluminum oxide adjuvant vaccine "Alorbat" in man (author's transl)].
    Desselberger U; Pressler K; Erdmann G
    Zentralbl Bakteriol Orig A; 1975 Jul; 232(2-3):160-77. PubMed ID: 1179878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamics and specificity of influenza virus antibodies as well as IgE values in serum and nasal fluid after repeated local application of live bivalent influenza vaccine.
    Werner J; Kuwert EK
    Dev Biol Stand; 1977 Jun 1-3; 39():135-40. PubMed ID: 604096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Field trial with a new type of influenza subunit vaccine (author's transl)].
    Kunz C; Hofmann H
    Wien Klin Wochenschr; 1976 Aug; 88(15):504-8. PubMed ID: 997532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of paramyxovirus-specific haemolysis-inhibiting antibodies separate from haemagglutinating-inhibiting and neuraminidase-inhibiting antibodies. 1. Sendai virus haemolysis-inhibiting antibodies.
    Orvell C
    Acta Pathol Microbiol Scand B; 1976 Dec; 84B(6):441-50. PubMed ID: 187012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the epidemiology of influenza. II. Persistence of HI antibody titers after the outbreaks of influenza A and B with respect to the different course of infection.
    Bruj J; Farník J
    Zentralbl Bakteriol Orig; 1970; 213(1):28-35. PubMed ID: 5460457
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antibody response to hemagglutinin and neuraminidase induced by an influenza subunit vaccine (author's transl)].
    Kuwert E; Werner J; Franke G; Paulus W
    Zentralbl Bakteriol Orig A; 1979 Jun; 244(1):1-16. PubMed ID: 92113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The value of complement fixation and haemagglutination inhibition tests in the diagnosis of influenza A.
    Pyhälä R; Kleemola M
    Acta Virol; 1976 Feb; 20(1):66-9. PubMed ID: 7943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the single radial hemolysis test for measuring hemagglutinin- and neuraminidase-specific antibodies to H3N2 influenza strains and antibodies to influenza B.
    Farrohi K; Farrohi FK; Noble GR; Kaye HS; Kendal AP
    J Clin Microbiol; 1977 Mar; 5(3):353-60. PubMed ID: 323281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influenza and influenza immunization.
    Fulginiti VA
    Ariz Med; 1976 Dec; 33(12):999-1006. PubMed ID: 797353
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use.
    Hehme N; Engelmann H; Kuenzel W; Neumeier E; Saenger R
    Virus Res; 2004 Jul; 103(1-2):163-71. PubMed ID: 15163505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new surface-antigen-adsorbed influenza virus vaccine. II. Studies in a volunteer group.
    Potter CW; Jennings R; McLaren C; Edey D; Stuart-Harris CH; Brady M
    J Hyg (Lond); 1975 Dec; 75(3):353-62. PubMed ID: 1059705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase.
    Couch RB; Atmar RL; Franco LM; Quarles JM; Wells J; Arden N; Niño D; Belmont JW
    J Infect Dis; 2013 Mar; 207(6):974-81. PubMed ID: 23307936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.